NCT05652023 Noninvasive Ultrasound Assessment of Detrusor Dysfunction
| NCT ID | NCT05652023 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Bladder Dysfunction |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,023 participants |
| Start Date | 2023-04-20 |
| Primary Completion | 2027-12-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,023 participants in total. It began in 2023-04-20 with a primary completion date of 2027-12-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to test a new ultrasound method called Quantitative Ultrasound Bladder Vibrometry to detect abnormal bladder function.
Eligibility Criteria
Inclusion Criteria: * Aim1: Age \>18 scheduled to undergo UDS for their clinical care for one of the included diagnoses. -Aim2: Inclusions: Age \>45 scheduled to undergo selective photovaporization of the prostate. Exclusion Criteria: * Aim1:Obesity (BMI \>35kg/m2), known neurologic disease impacting bladder function (e.g. spinal cord injury, multiple sclerosis, Parkinson's, prior cerebrovascular accident), previous pelvic radiation therapy, previous radical pelvic surgery (such as for uterine or colorectal cancer), prior bladder surgery (including prostate resection), and pregnant or breast-feeding women. * Aim2:Obesity (BMI \>35kg/m2), known neurologic disease impacting bladder function (e.g. spinal cord injury, multiple sclerosis, Parkinson's, prior cerebrovascular accident), previous pelvic radiation therapy, previous radical pelvic surgery (such as colorectal cancer).
Contact & Investigator
Azra Alizad, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT05652023 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Bladder Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05652023 currently recruiting?
Yes, NCT05652023 is actively recruiting participants. Contact the research team at alizad.azra@mayo.edu for enrollment information.
Where is the NCT05652023 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT05652023 clinical trial?
NCT05652023 is sponsored by Mayo Clinic. The principal investigator is Azra Alizad, MD at Mayo Clinic. The trial plans to enroll 2,023 participants.